19-3594937-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001060.6(TBXA2R):c.*751C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00026 in 1,536,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 0 hom. )
Consequence
TBXA2R
NM_001060.6 3_prime_UTR
NM_001060.6 3_prime_UTR
Scores
1
1
14
Clinical Significance
Conservation
PhyloP100: -0.951
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.027985603).
BP6
Variant 19-3594937-G-A is Benign according to our data. Variant chr19-3594937-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3354230.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.*751C>T | 3_prime_UTR_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | ||
TBXA2R | NM_201636.3 | c.1123C>T | p.Arg375Trp | missense_variant | 4/4 | NP_963998.2 | ||
TBXA2R | XM_011528214.3 | c.*751C>T | 3_prime_UTR_variant | 4/4 | XP_011526516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.*751C>T | 3_prime_UTR_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336 | P1 | ||
TBXA2R | ENST00000589966.1 | c.*614C>T | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000468145 | ||||
TBXA2R | ENST00000411851.3 | c.1123C>T | p.Arg375Trp | missense_variant | 4/4 | 2 | ENSP00000393333 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152226Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000203 AC: 29AN: 142670Hom.: 0 AF XY: 0.000157 AC XY: 12AN XY: 76558
GnomAD3 exomes
AF:
AC:
29
AN:
142670
Hom.:
AF XY:
AC XY:
12
AN XY:
76558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000261 AC: 361AN: 1383876Hom.: 0 Cov.: 30 AF XY: 0.000231 AC XY: 158AN XY: 682860
GnomAD4 exome
AF:
AC:
361
AN:
1383876
Hom.:
Cov.:
30
AF XY:
AC XY:
158
AN XY:
682860
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74506
GnomAD4 genome
AF:
AC:
39
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
15
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TBXA2R-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 23, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
D
Sift4G
Pathogenic
D
Vest4
MutPred
Loss of disorder (P = 0.0272);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at